Results 201 to 210 of about 202,276 (321)

The impact of BCL-2/MYC protein expression and gene abnormality on primary central nervous system diffuse large B-cell lymphoma.

, 2019
Wenjuan Yin, Xianghou Xia, Meijuan Wu, Haiyang Yang, Xiu Zhu, Wenyong Sun, Minghua Ge   +6 more
openalex   +1 more source

Clinical Benefits of Arterial Spin-Labeling Magnetic Resonance Imaging for Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Presenting With Lymphomatosis Cerebri: A Case Report [PDF]

Akira Okazaki, Tomohiro Yamasaki, Eri Kataoka, Mayu Fujihiro, Kazuhiko Kurozumi   +4 more
openalex   +1 more source

A PHASE I STUDY OF IBRUTINIB COMBINED WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH RELAPSED OR PRIMARY REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA [PDF]

, 2017
Craig S. Sauter, Matthew J. Matasar, Heiko Schöder, Pamela Drullinsky, John F. Gerecitano, Anita Kumar, Ariela Noy, M. Lia Palomba, C. Portlock, David J. Straus, Andrew D. Zelenetz, S.S. McCall, Shoshana T. Miller, Amanda I. Courtien, Anas Younes, Craig H. Moskowitz   +15 more
openalex   +1 more source

Tafasitamab as Monotherapy or in Combination in Japanese Patients With B‐Cell Non‐Hodgkin Lymphoma: Results From the Phase 1b J‐MIND Study

Cancer Science, EarlyView.
J‐MIND evaluated the safety and tolerability of tafasitamab, a CD19‐targeting monoclonal antibody, alone or in combination with other therapies in Japanese patients with B‐cell non‐Hodgkin lymphoma (NHL). Most common treatment‐emergent adverse events across all groups were hematological, and no serious tafasitamab treatment‐related or fatal adverse ...
Koji Izutsu, Noriko Fukuhara, Junichiro Yuda, Youko Suehiro, Shigeru Kusumoto, Marie‐Laure Casadebaig, Kazumi Suzukawa, Kentaro Fukushima   +7 more
wiley   +1 more source

Identification of Differentially Expressed Prognostic and Diagnostic Genes in Diffuse Large B-Cell Lymphoma

Narjes Seddighi, Aidin Darbeh, Hamid Tanzadehpanah, Atousa Ghorbani, Saeed Samaeinasab, Abbas Ahmadi, Mahdieh Sadeghigovarbandi, Ehsan Saburi   +7 more
openalex   +1 more source

Additional file 1: Table S1. of Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma

, 2017
Wenting Huang, Xuemin Xue, Ling Shan, Tian Qiu, Lei Guo, Jianming Ying, Ning Lü   +6 more
openalex   +1 more source

Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis

, 2020
Pankaj Nepal, Prem P. Batchala, Patrice K. Rehm, Camilo E. Fadul   +3 more
openalex   +2 more sources

Characterization of the MIR23A Cluster in Diffuse Large B Cell Lymphoma [PDF]

, 2017
Natalie Veronika Freytag
openalex   +1 more source

Precision Oncology for Pediatric Solid Tumors Using In‐Hospital Pediatric/AYA Malignancy‐Specific Panel Sequencing

Cancer Science, EarlyView.
Our findings indicate that a pediatric/AYA‐specific targeted panel deployed in a hospital can deliver rapid, clinically actionable molecular insights with high diagnostic and prognostic yield. This complements larger sequencing platforms by offering speed, focused content, and easier interpretation.
Masato Kojima, Sho Kurihara, Isamu Saeki, Ryo Touge, Keigo Nakashima, Shuhei Karakawa, Fumiyuki Yamasaki, Satoshi Okada, Eiso Hiyama   +8 more
wiley   +1 more source

Tafasitamab in refractory diffuse large B-cell lymphoma with neurolymphomatosis [PDF]

João Mendes, Laurine Couleur, Claudia Manca, Valérie Frossard, Mitja Nabergoj   +4 more
openalex   +1 more source